Diagonal Bio AB Financial Flexibility Index
Diagonal Bio AB financial flexibility index. Diagonal Bio AB (DIABIO) has a Financial Flexibility Index of -1.07x as of September 2025. Free cash flow of Skr-2.27 Million (operating CF Skr-2.27 Million minus capex Skr0.00) represents -1% of total liabilities (Skr2.13 Million). See Diagonal Bio AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Diagonal Bio AB (2020–2024)
Financial flexibility index of Diagonal Bio AB from 2020 to 2024. Historical Financial Flexibility Index trend for Diagonal Bio AB across 5 annual periods. Explore Diagonal Bio AB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Diagonal Bio AB Financial Flexibility Index by Year (2020–2024)
Diagonal Bio AB financial flexibility index by year from 2020 to 2024. Year-by-year free cash flow to debt coverage for Diagonal Bio AB. For the full cash flow conversion analysis, see cash flow conversion of Diagonal Bio AB.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.77x | Skr-12.10 Million | Skr-13.77 Million | Skr2.54 Million | ▼ -3412.7% |
| 2023 | -0.14x | Skr-985.00K | Skr-5.23 Million | Skr7.26 Million | ▲ +96.5% |
| 2022 | -3.90x | Skr-10.82 Million | Skr-15.77 Million | Skr2.78 Million | ▼ -255.5% |
| 2021 | -1.10x | Skr-2.35 Million | Skr-10.94 Million | Skr2.14 Million | ▼ -622.0% |
| 2020 | 0.21x | Skr226.67K | Skr226.67K | Skr1.08 Million | — |